Declan G. Murphy
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
Papers in
-
- Prostate Cancer Diagnosis and Treatment 192
- Prostate Cancer Treatment and Research 64
- Renal cell carcinoma treatment 22
-
- Medical Imaging Techniques and Applications 38
- Radiopharmaceutical Chemistry and Applications 35
- Co-authors
- Nathan Lawrentschuk (115 shared papers)Prof Michael S. Hofman (59 shared papers)Damien Michael Bolton (34 shared papers)Marlon Perera (32 shared papers)Nathan P. Papa (16 shared papers)Daniel Christidis (3 shared papers)Scott Williams (22 shared papers)Anthony J. Costello (40 shared papers)
- Journals
- British Journal of Urology (84 papers)European Urology (49 papers)European Urology Oncology (12 papers)The Lancet Oncology (11 papers)The Journal of Urology (11 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Declan G. Murphy
365 papers receiving 15.7k citations
Declan G. Murphy's Hit Papers
Peers
Comparison fields: 5 of 144
- Pulmonary and Respiratory Medicine 9.5k
- Radiology, Nuclear Medicine and Imaging 4.8k
- Health Informatics 159
- Health 434
- Urology 275
Countries citing papers authored by Declan G. Murphy
This map shows the geographic impact of Declan G. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan G. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan G. Murphy more than expected).
Fields of papers citing papers by Declan G. Murphy
This network shows the impact of papers produced by Declan G. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan G. Murphy. The network helps show where Declan G. Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Declan G. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study Hit paper breakdown → | 2020 | 1450 |
| 2 | [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study Hit paper breakdown → | 2018 | 940 |
| 3 | Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis Hit paper breakdown → | 2016 | 820 |
| 4 | Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis Hit paper breakdown → | 2019 | 725 |
| 5 | The Lancet Commission on prostate cancer: planning for the surge in cases Hit paper breakdown → | 2024 | 407 |
| 6 | Dosimetry of 177 Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes Hit paper breakdown → | 2018 | 395 |
| 7 | Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy Hit paper breakdown → | 2015 | 345 |
| 8 | The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study Hit paper breakdown → | 2021 | 313 |
| 9 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 Hit paper breakdown → | 2020 | 309 |
| 10 | Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis Hit paper breakdown → | 2020 | 268 |
| 11 | 2018 | 265 | |
| 12 | Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177 Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2019 | 242 |
| 13 | PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial Hit paper breakdown → | 2022 | 209 |
| 14 | 2013 | 201 | |
| 15 | 2017 | 192 | |
| 16 | 2019 | 186 | |
| 17 | 2017 | 175 | |
| 18 | 2012 | 165 | |
| 19 | Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial Hit paper breakdown → | 2023 | 160 |
| 20 | 2014 | 159 |
About Declan G. Murphy
Declan G. Murphy is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Urology, Surgery and Health, having authored 383 papers that have together received 15.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (192 papers), Prostate Cancer Treatment and Research (64 papers), Medical Imaging Techniques and Applications (38 papers), Radiopharmaceutical Chemistry and Applications (35 papers), Renal cell carcinoma treatment (22 papers), Urinary Bladder and Prostate Research (18 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Minimally Invasive Surgical Techniques (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.5k citations), Radiology, Nuclear Medicine and Imaging (4.8k citations), Health Informatics (159 citations), Health (434 citations) and Urology (275 citations). Declan G. Murphy has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Nathan Lawrentschuk, Prof Michael S. Hofman, Damien Michael Bolton, Marlon Perera, Nathan P. Papa, Daniel Christidis, Scott Williams, Anthony J. Costello, Rodney J. Hicks and Mark Frydenberg. Their work appears in journals such as British Journal of Urology, European Urology, European Urology Oncology, The Lancet Oncology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.